Clinical characteristics and quality of life of persistent symptoms of COVID-19 syndrome in Indonesia

Susanto, Agus Dwi; Isbaniah, Fathiyah; Pratomo, Irandi Putra; Antariksa, Budhi; Samoedro, Erlang; Taufik, Muhammad; Harinda, Fadlika; Nurwidya, Fariz

doi:10.18683/germs.2022.1319

Cited by 7 publications

(10 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It is in line with a study conducted by (Susanto et al, 2022) which shows that 256 respondents (66.5%) of 385 respondents have the post-COVID-19 syndrome. The majority of respondents were women aged 18-40 years.…”

Section: Discussionsupporting

confidence: 91%

“…The most commonly complained symptom is anxiety or depression. A total of 16.8% of subjects with COVID-19 reported persistent symptoms for more than 3 months (Susanto et al, 2022). Study conducted at the University of Ottawa on the increase in insomnia cases involving 190,000 participants in post-COVID-19 patients found that the level of depression, anxiety, and Post Traumatic Stress Disorder (PTSD) increased by 23.87% compared to before the Covid-19 pandemic (LPM Sinovia, 2020).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The Effect of Clitoria Ternatea's Drink on Insomnia in Post COVID-19 Patients

Solihati¹,

Kusumastuti²

2023

J HEALTH PROMOT BEHAV

View full text Add to dashboard Cite

Background:The COVID-19 pandemic evokes an effect on patients of post-COVID-19. One of them is diminished sleep quality known as insomnia. Concerning the problem, WHO strongly supports the supportive supplementary medicines made from traditional plants during the COVID-19 pandemic, one of which is by utilizing butterfly pea flowers. The study aimed to determine the effect of butterfly pea flower drinks on insomnia in post-COVID-19 patients Subjects and Method: This was a randomized controlled trial. The population in this study was 36 respondents who experienced insomnia post-COVID-19. The sampling technique used was simple random sampling. The total sample of 32 respondents was divided into 2 groups, namely 16 respondents as an intervention group and 16 respondents as a control group. This research was conducted for 14 days, from September 18 to October 3, 2022, at the Islamic Housing Complex, Neighborhood Unit 001, Kelapa Dua, Tangerang Regency. The independent variable in this study was the administration of butterfly pea flower drink and the dependent variable was insomnia. The study instruments used were observation sheets for the administration of butterfly pea flower drink and the Insomnia Rating Scale (IRS) questionnaire for the insomnia variable. The study used an independent t-test for data analysis. Results: Independent t-test results indicated that the intervention group (Mean= -4.31 SD= 3.70) was lower than the control group (Mean= -0.38; SD= 2.50), and the result was statistically significant (p= 0.001). Conclusion:There is an effect of butterfly pea flower drink on insomnia in post-COVID-19 patients.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionmentioning

confidence: 99%

The Effect of Clitoria Ternatea's Drink on Insomnia in Post COVID-19 Patients

Solihati¹,

Kusumastuti²

2023

J HEALTH PROMOT BEHAV

View full text Add to dashboard Cite

show abstract

“…Our results resembled the observation from a small cohort assessed with four different questionnaires before and 6 months after hospitalization due to COVID‐19 that revealed a decrease in QoL, especially in younger individuals, that was, between 41 and 60 years 24 . On the other hand, an online questionnaire survey of 385 Indonesian patients showed that the risk of persistent post‐COVID fatigue, affecting QoL in the aspect of pain and anxiety or depression, was increased in older people and those previously hospitalized 25 . Thus, as it has been shown in a recent meta‐analysis, both in younger and older COVID‐19 survivors, symptoms of the CFS, such as fatigue, headache, and myalgia, are highly prevalent, and possibly associated with a poorer QoL 26 …”

Section: Discussionmentioning

confidence: 99%

“…24 On the other hand, an online questionnaire survey of 385 Indonesian patients showed that the risk of persistent post-COVID fatigue, affecting QoL in the aspect of pain and anxiety or depression, was increased in older people and those previously hospitalized. 25 Thus, as it has been shown in a recent meta-analysis, both in younger and older COVID-19 survivors, symptoms of the CFS, such as fatigue, headache, and myalgia, are highly prevalent, and possibly associated with a poorer QoL. 26 Many possible explanations for fatigue-inducing QoL impairment in patients after SARS-CoV-2 infection have been proposed.…”

Section: Discussionmentioning

confidence: 99%

Quality of life at work and fatigue after hospitalization due to COVID‐19

Mazurkiewicz,

Chatys‐Bogacka,

Slowik

et al. 2023

Neurology & Clinical Neurosc

View full text Add to dashboard Cite

ObjectiveTo evaluate course of quality of life (QoL) after hospitalization due to COVID‐19 and to assess whether symptoms of chronic fatigue syndrome (CFS) were its predictors at different time points.MethodsParticipants aged 18 or older retrospectively reported QoL at work with 4‐point Likert scale and presence of eight CFS symptoms before infection, within 0–4, 4–12, and > 12 weeks post‐COVID with online or paper version of validated neuropsychological questionnaire.ResultsTwo hundred and eighty‐three patients (median age 59 [47–67] years, 37.45% women, 95.76% non‐ICU residents) were evaluated after median of 27.1 (24.9–31.6) weeks from first positive swab test for SARS‐CoV‐2. Any decrease in QoL at work was observed in 33.21%, 29.28%, and 25.54% of patients within 4, 4–12, and > 12 weeks after COVID‐19, respectively (p < 0.001). Within 4 weeks after COVID‐19 onset, decrease in QoL at work was predicted by age (OR = 0.93, 95% CI:0.90–0.96, p < 0.001), persistent fatigue unrelated to effort (OR = 4.03, 95% CI:1.21–13.50, p < 0.001), sore throat (OR = 5.33, 95% CI:1.92–14.78, p = 0.001), and prolonged post‐exercise fatigue (OR = 8.12, 95% CI:2.17–30.56, p = 0.002). Predictors of deterioration in QoL at work 4–12 and > 12 weeks post‐infection were age (OR = 0.97, 95% CI:0.94–0.99, p = 0.015 and OR = 0.93, 95% CI:0.90–0.97, p = 0.001, respectively), non‐restorative sleep (OR = 2.75, 95% CI:1.25–6.05, p = 0.012 and OR = 3.62, 95% CI:1.40–9.38, p = 0.008, respectively), and headache (OR = 2.78, 95% CI:1.29–5.99, p = 0.009 and OR = 5.68, 95% CI:2.15–15.02, p < 0.001, respectively). Furthermore, decreased QoL at work was predicted by post‐exercise fatigue (OR = 5.99, 95% CI:2.18–16.20, p < 0.001) and fatigue not caused by effort (OR = 14.40, 95% CI:4.77–43.45, p < 0.001) within 4–12 and > 12 weeks post‐infection, respectively.ConclusionsDifferent CFS symptoms are associated with decreased QoL at work at various time points since COVID‐19 onset.

show abstract

“…In a limited study in Indonesia in 2021, it was stated that out of a total of 385 respondents, 256 (66.5%) had persistent COVID-19 syndrome. The most common symptoms were fatigue (29.4%), cough (15.5%), and muscle aches (11.2%) (2). In the evaluation of patients with lung disease after COVID-19, most patients with radiographic abnormalities will have accompanying symptoms, namely shortness of breath with or without coughing, or physiological abnormalities in the lungs (3).…”

Section: Introductionmentioning

confidence: 99%

Predicting lung abnormality and severity in chest imaging after COVID-19: Is there a clue based on the clinical spectrum during illness?

Widyaningtiyas¹,

Widyoningroem²,

Sensusiati³

2022

IJRP

View full text Add to dashboard Cite

Background: Complaints after COVID-19 have been widely reported, especially those related to the respiratory tract. This situation may be related to the presence of lung lesions even though the patient has been cured as evidenced by negative PCR results. Chest CT scan is a good imaging modality that can be used to follow up post-COVID-19 patients. This study aims to determine the characteristics of a negative post-conversion chest CT scan and the correlation of the clinical spectrum of illness and lesions in a chest CT scan.Method: This study is an analytic observational type with a retrospective approach. Researchers will examine the medical records of confirmed COVID-19 patients who are hospitalized at Dr. Soetomo and had a negative post-conversion chest CT scan at Dr. Soetomo Hospital. The severity system uses a modified severity level, then a statistical correlation analysis test is carried out with the Spearman Test.Result: Total sample was 79 patients, with 46 male subjects (58,2 %) and 33 female subjects (41,8 %). From the clinical spectrum of illness, as many as 0% of patients were asymptomatic, 30.4% with mild symptoms, 25.3% with moderate symptoms, 17.7% with severe symptoms/severe pneumonia, and 26.6% with critical symptoms. Of the 79 samples, 93.7% had pulmonary abnormalities. The most abnormalities that were found were fibrosis at 88.6% and ground glass opacity (GGO) at 78.5%. Conclusion:Even though the patient has been declared cured of COVID-19 with a negative RT-PCR result, there are still abnormalities in the patient's lungs. A significant correlation between clinical spectrum with pulmonary severity was found

show abstract

Clinical characteristics and quality of life of persistent symptoms of COVID-19 syndrome in Indonesia

Cited by 7 publications

References 20 publications

The Effect of Clitoria Ternatea's Drink on Insomnia in Post COVID-19 Patients

The Effect of Clitoria Ternatea's Drink on Insomnia in Post COVID-19 Patients

Quality of life at work and fatigue after hospitalization due to COVID‐19

Predicting lung abnormality and severity in chest imaging after COVID-19: Is there a clue based on the clinical spectrum during illness?

Contact Info

Product

Resources

About